Unichem Laboratories · NSE: UNICHEMLAB · BSE: 506690
Q3 FY23 results · Oct–Dec 2022
Unichem Laboratories reported revenue from operations of ₹302.50 crore (down 2.8% from Q3 FY22) and net loss of ₹63.93 crore for Q3 FY23 (Oct–Dec 2022), on a consolidated basis.
| Item | Q3 FY23 | Q3 FY22 | YoY | Q2 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 302.50 | 311.31 | −2.8% | 328.82 | −8.0% |
| Other income | 16.35 | 14.66 | +11.5% | 9.21 | +77.6% |
| Total income | 318.85 | 325.96 | −2.2% | 338.02 | −5.7% |
| Profit before tax | (61.28) | (10.64) | Loss widened | (47.25) | Loss widened |
| Net profit for the period | (63.93) | (14.10) | Loss widened | (70.67) | Loss narrowed |
| EPS, basic (₹) | (9.08) | (2.01) | Loss widened | (10.04) | Loss narrowed |
| Net margin (%) | -21.1 | -4.5 | -21.5 |
| Item | Q3 FY23 | Q3 FY22 | YoY | Q2 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 251.95 | 248.29 | +1.5% | 265.64 | −5.2% |
| Other income | 15.43 | 15.09 | +2.3% | 10.78 | +43.2% |
| Total income | 267.38 | 263.38 | +1.5% | 276.42 | −3.3% |
| Profit before tax | (57.12) | (23.50) | Loss widened | (54.85) | Loss widened |
| Net profit for the period | (57.12) | (23.50) | Loss widened | (75.46) | Loss narrowed |
| EPS, basic (₹) | (8.11) | (3.34) | Loss widened | (10.72) | Loss narrowed |
| Net margin (%) | -22.7 | -9.5 | -28.4 |
Consolidated
- Filed with BSE
- 07 Feb 2023, 16:57 IST
- Board meeting
- 06 Feb 2023
- Period
- 01 Oct 2022 to 31 Dec 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 07 Feb 2023, 16:57 IST
- Board meeting
- 06 Feb 2023
- Period
- 01 Oct 2022 to 31 Dec 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE